Estrogen Induces c-myc Gene Expression via an Upstream Enhancer Activated by the Estrogen Receptor and the AP-1 Transcription Factor
Open Access
- 1 September 2011
- journal article
- research article
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 25 (9), 1527-1538
- https://doi.org/10.1210/me.2011-1037
Abstract
C-myc oncogene is implicated in tumorigenesis of many cancers, including breast cancer. Although c-myc is a well-known estrogen-induced gene, its promoter has no estrogen-response element, and the underlying mechanism by which estrogen induces its expression remains obscure. Recent genome-wide studies by us and others suggested that distant elements may mediate estrogen induction of gene expression. In this study, we investigated the molecular mechanism by which estrogen induces c-myc expression with a focus on these distal elements. Estrogen rapidly induced c-myc expression in estrogen receptor (ER)-positive breast cancer cells. Although estrogen had little effect on c-myc proximal promoter activity, it did stimulate the activity of a luciferase reporter containing a distal 67-kb enhancer. Estrogen induction of this luciferase reporter was dependent upon both a half-estrogen response element and an activator protein 1 (AP-1) site within this enhancer, which are conserved across 11 different mammalian species. Small interfering RNA experiments and chromatin immunoprecipitation assays demonstrated the necessity of ER and AP-1 cross talk for estrogen to induce c-myc expression. TAM67, the AP-1 dominant negative, partially inhibited estrogen induction of c-myc expression and suppressed estrogen-induced cell cycle progression. Together, these results demonstrate a novel pathway of estrogen regulation of gene expression by cooperation between ER and AP-1 at the distal enhancer element and that AP-1 is involved in estrogen induction of the c-myc oncogene. These results solve the long-standing question in the field of endocrinology of how estrogen induces c-myc expression.Keywords
This publication has 49 references indexed in Scilit:
- Effect of Lapatinib on the Development of Estrogen Receptor–Negative Mammary Tumors in MiceJNCI Journal of the National Cancer Institute, 2009
- Rexinoid-induced Expression of IGFBP-6 Requires RARβ-dependent Permissive Cooperation of Retinoid Receptors and AP-1Online Journal of Public Health Informatics, 2009
- Reflecting on 25 years with MYCNature Reviews Cancer, 2008
- Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathwaysJournal of Molecular Endocrinology, 2008
- Whole-Genome Cartography of Estrogen Receptor α Binding SitesPLoS Genetics, 2007
- Global mapping of c-Myc binding sites and target gene networks in human B cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- Genome-wide analysis of estrogen receptor binding sitesNature Genetics, 2006
- AP-1 blockade inhibits the growth of normal and malignant breast cellsOncogene, 2001
- Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated TranscriptionCell, 2000
- C-myc gene chromatin of estrogen receptor positive and negative breast cancer cellsMolecular and Cellular Endocrinology, 1993